Announcement on Acceptance of Marketing Authorization Application for Vilacita Monoclonal Antibody Injection (BAT5906)

About this update from Bio-thera Solutions, Ltd. Class A

Announcement on Acceptance of Marketing Authorization Application for Vilacita Monoclonal Antibody Injection (BAT5906) The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Bio-thera Solutions, Ltd. Class A